LITUMBIA

Serial Number 98210782
730

Registration Progress

Application Filed
Oct 5, 2023
Under Examination
Aug 6, 2024
Approved for Publication
Jun 11, 2024
Published for Opposition
Jun 11, 2024
Registered

Attorney Assistance

Statement of Use Due - Extension 1 Granted
Due: Aug 06, 2025 14 days

Trademark Image

LITUMBIA

Basic Information

Serial Number
98210782
Filing Date
October 5, 2023
Published for Opposition
June 11, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
730
Status Date
Feb 1, 2025
Application
Pending
Classes
005

Rights Holder

Genentech, Inc.

03
Address
1 DNA Way
South San Francisco, CA 94080

Ownership History

Genentech, Inc.

Original Applicant
03
South San Francisco, CA

Genentech, Inc.

Owner at Publication
03
South San Francisco, CA

Legal Representation

Attorney
Jelena Libby

USPTO Deadlines

Next Deadline
14 days remaining
Statement of Use Due - Extension 1 Granted
Due Date
August 06, 2025
Extension Available
Until August 06, 2025

Application History

12 events
Date Code Type Description Documents
Feb 1, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 1, 2025 EX1G S SOU EXTENSION 1 GRANTED Loading...
Feb 1, 2025 EXT1 S SOU EXTENSION 1 FILED Loading...
Jan 31, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Aug 6, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jun 11, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jun 11, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
May 22, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
May 6, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
May 3, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 14, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Oct 9, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for use in oncology

Classification

International Classes
005